Stress Echocardiography Study With Regadenoson

Clinical trial NCT00907764 · TERMINATED

Trial details

NCT number: NCT00907764
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Disease Coronary Artery Disease

Start date: 2009-04-01
Primary completion: 2010-04-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.